Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $50 Million At-The-Market Offering Facility

Press Release – New York, NY – March 23, 2022 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”), a medical diagnostic and consumer healthcare technology company, in a $50 million At-The-Market offering facility (“ATM”).
The shares were registered on BTCY’s Registration Statement on Form S-3 (File No. 333-255544) filed with the Securities and Exchange Commission on April 27, 2021, and declared effective by the SEC on May 4, 2021, and the prospectus supplement relating to the ATM filed with the SEC on March 22, 2022.
H.C. Wainwright acted as agent for the ATM.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and David Manno, and associates Matt Siracusa and Rajiv Radia.
- Sichenzia Ross Ference LLP Joins Splash Beverage Group, Inc. in Ringing Opening Bell at NYSE - July 29, 2022
- Sichenzia Ross Ference LLP Represents Roth Capital Partners in Public Offering of Common Stock of Crown Electrokinetics Corp. - July 26, 2022
- Sichenzia Ross Ference LLP Represents ShiftPixy Inc. in a $1.3 Million Warrant Exchange and Exercise - July 20, 2022